MDGL - Madrigal Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts11111212
Avg. Estimate-1.52-1.81-5.83-8.23
Low Estimate-2.44-3.1-8.3-13.87
High Estimate-1.18-1.36-4.86-5.41
Year Ago EPS-0.56-0.75-2.22-5.83
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts8899
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.53-0.74-0.97-1.2
EPS Actual-0.56-0.75-0.98-1.28
Difference-0.03-0.01-0.01-0.08
Surprise %-5.70%-1.40%-1.00%-6.70%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-1.52-1.81-5.83-8.23
7 Days Ago-1.5-1.79-5.79-8.13
30 Days Ago-1.41-1.66-5.56-8.13
60 Days Ago-1.42-1.63-5.21-6.97
90 Days Ago-1.38-1.6-5.23-7.03
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days111N/A
Up Last 30 DaysN/AN/A1N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1112
Growth EstimatesMDGLIndustrySectorS&P 500
Current Qtr.-171.40%N/AN/A-0.01
Next Qtr.-141.30%N/AN/A0.07
Current Year-162.60%N/AN/A-0.01
Next Year-41.20%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A